Immediate Impact
2 standout
Citing Papers
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)
2024 Standout
Real-world COVID-19 vaccine effectiveness against the Omicron BA.2 variant in a SARS-CoV-2 infection-naive population
2023 Standout
Works of Honey Dave being referenced
Evaluation of Commercially Available High-Throughput SARS-CoV-2 Serologic Assays for Serosurveillance and Related Applications
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Honey Dave | 44 | 4 | 3 | 8 | 4 | 5 | 48 | |
| Mónica Becerra-Wong | 50 | 3 | 3 | 16 | 4 | 5 | 58 | |
| Haocheng Ye | 41 | 2 | 12 | 2 | 4 | 50 | ||
| Van Phu Tran | 34 | 7 | 6 | 4 | 3 | 8 | 57 | |
| Amanda Kita-Yarbro | 37 | 3 | 8 | 12 | 3 | 44 | ||
| Anja Coen | 25 | 3 | 1 | 7 | 14 | 6 | 33 | |
| Christine Kosmos | 34 | 4 | 3 | 6 | 2 | 5 | 48 | |
| Susan L. Dobson | 35 | 13 | 2 | 10 | 4 | 4 | 52 | |
| Allison Fialkowski | 20 | 8 | 4 | 3 | 3 | 7 | 43 | |
| My Linh Ly | 54 | 10 | 2 | 11 | 2 | 7 | 63 | |
| Ahad Al Seraihi | 25 | 10 | 3 | 4 | 5 | 5 | 42 |
All Works
Login with ORCID to disown or claim papers
Loading papers...